Visit the DoD SBIR/STTR Opportunities website for detailed information on the solicitation and topics.
In medial collateral ligament (MCL) injury models, BPC-157 administered intraperitoneally (10 g or 10 ng/kg once daily), topically as a cream layer, or orally in drinking water consistently produced functional, biomechanical, macroscopic, and histological healing improvements throughout the 90-day study period
This is ingredient-level research
BPC-157 Injection: Methods, Sites, and What to Expect BPC-157 is most commonly administered by injection subcutaneous or intramuscular though oral administration (tablets or capsules) is a topic worth addressing separately
Regulatory oversight is minimal in most jurisdictions, and compounded peptide sources lack standardized quality assurance comparable to FDA-regulated pharmaceuticals
Nichole Campbell, MSN, APRN, NP-C Katie Boatler, RN, BSN Kaytlin Krutsch, PhD, PharmD, MBA, BCPS References: 1